sm

Steve Mott joins DrugLogic

pharmafile | October 5, 2011 | Appointment | Research and Development appointment, outcomes research, personalised medicine, pharmacovigilance, research and development 

Former Datapharm Communications chief executive Steve Mott has been apppointed UK managing director by DrugLogic.

The US firm develops analytical tools that help companies manage real world clinical data and Steve will oversee its expansion into Europe.

Related Content

How COVID-19 has changed pharmacovigilance

The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 …

what-is-pharmacovigilance-328154

The need for evolution in pharmacovigilance

Pharmacovigilance is a critical function in ensuring public health, but is our current system built …

pharmafocus_march_2020_cover

The March 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus, the March issue, is available to read for free …

Latest content